help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Møller, A. M.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Møller, A. M.
Right arrow Articles by Pedersen, O.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
Medline Plus Health Information
*Diabetes
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 2181-2186
Copyright © 2001 by The Endocrine Society


Original Studies

Studies of Genetic Variability of the Glucose Transporter 2 Promoter in Patients with Type 2 Diabetes Mellitus

Ann M. Møller, Niels M. Jensen, Julie Pildal, Thomas Drivsholm, Knut Borch-Johnsen, Søren A. Urhammer, Torben Hansen and Oluf Pedersen

Steno Diabetes Center and Hagedorn Research Institute (A.M.M., N.M.J., J.P., K.B.-J., S.A.U., T.H., O.P.), DK-2820 Gentofte, Copenhagen, Denmark; and Centre of Preventive Medicine (T.D., K.B.-J.), Glostrup University Hospital, DK-2600 Glostrup, Denmark

Address all correspondence and requests for reprints to: Ann Merete Møller, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Copenhagen, Denmark.

This study was performed to test the hypothesis that genetic variation in the promoter of the glucose transporter 2 (GLUT2) might predispose to prediabetic phenotypes or type 2 diabetes. A total of 1611 bp comprising the minimal promoter region of the GLUT2 gene were examined by combined single-strand conformational polymorphism and heteroduplex analysis followed by direct sequencing of identified variants on genomic DNA from 96 randomly recruited Danish type 2 diabetic patients. We identified 4 nucleotide variants, -447g->a, -149c->a, -122t->c, and -44g->a. None of the variants were positioned in known or presumed transcription factor binding sites, TATA-box, or transcriptional start site. Association studies of the -149c->a, -122t->c, and -44g->a variants revealed that the variants were as prevalent in 320 type 2 diabetic patients [11.0% (95% confidence interval, 8.4–13.6), 9.8% (7.4–12.2), and 29.0% (24.4–33.6), respectively] as in 241 age-matched glucose-tolerant subjects [13.1% (9.8–16.4), 11.2% (8.3–14.1), and 33.4% (28.8–38.0), respectively]. The -447g->a mutation was only identified in a single diabetic patient and did not show cosegregation with diabetes in the family of the proband. The three common variants showed in a primary genotype-phenotype study comprising 241 glucose-tolerant middle-aged subjects association to increased plasma glucose levels during an oral glucose tolerance test. However, this result could not be replicated in a second sample of 298 60-yr-old glucose-tolerant subjects.

In conclusion, we found no evidence supporting the hypothesis that genetic variability in the minimal promoter of the GLUT2 is associated with type 2 diabetes or prediabetic phenotypes in the Danish population.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
K. M. Eny, T. M. S. Wolever, B. Fontaine-Bisson, and A. El-Sohemy
Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations
Physiol Genomics, May 1, 2008; 33(3): 355 - 360.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al.
Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes
Physiol Genomics, October 19, 2007; 31(2): 264 - 272.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. Laukkanen, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, M. Uusitupa, and M. Laakso
Polymorphisms in the SLC2A2 (GLUT2) Gene Are Associated With the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study
Diabetes, July 1, 2005; 54(7): 2256 - 2260.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. M. Frayling, C. M. Lindgren, J. C. Chevre, S. Menzel, M. Wishart, Y. Benmezroua, A. Brown, J. C. Evans, P. S. Rao, C. Dina, et al.
A Genome-Wide Scan in Families With Maturity-Onset Diabetes of the Young: Evidence for Further Genetic Heterogeneity
Diabetes, March 1, 2003; 52(3): 872 - 881.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J.-y. Cha, H.-s. Kim, H.-i. Kim, S.-s. Im, S.-y. Kim, J.-w. Kim, B.-i. Yeh, and Y.-h. Ahn
Analysis of Polymorphism of the GLUT2 Promoter in NIDDM Patients and its Functional Consequence to the Promoter Activity
Ann. Clin. Lab. Sci., April 1, 2002; 32(2): 114 - 122.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society